Rocky Mountain Chocolate Factory Faces Delisting Concerns
Ticker: RMCF · Form: 8-K · Filed: Nov 20, 2024 · CIK: 1616262
| Field | Detail |
|---|---|
| Company | Rocky Mountain Chocolate Factory, Inc. (RMCF) |
| Form Type | 8-K |
| Filed Date | Nov 20, 2024 |
| Risk Level | high |
| Pages | 4 |
| Reading Time | 4 min |
| Key Dollar Amounts | $0.001 |
| Sentiment | bearish |
Sentiment: bearish
Topics: delisting, listing-standards, compliance
TL;DR
RMCF might get delisted - stock exchange rules are a problem.
AI Summary
Rocky Mountain Chocolate Factory, Inc. (RMCF) filed an 8-K on November 20, 2024, reporting a notice of delisting or failure to satisfy a continued listing rule. The company's principal executive offices are located at 265 Turner Drive, Durango, Colorado.
Why It Matters
This filing indicates potential issues with Rocky Mountain Chocolate Factory's compliance with stock exchange listing standards, which could impact its stock's tradability and investor confidence.
Risk Assessment
Risk Level: high — A notice of delisting or failure to meet listing standards poses a significant risk to the company's stock trading and overall financial health.
Key Numbers
- 001-36865 — Commission File Number (Identifies the company's SEC filing history.)
- 47-1535633 — IRS Employer Identification No. (Company's tax identification number.)
Key Players & Entities
- Rocky Mountain Chocolate Factory, Inc. (company) — Registrant
- 265 Turner Drive, Durango, Colorado 81303 (location) — Principal executive offices
- November 14, 2024 (date) — Earliest event reported
- November 20, 2024 (date) — Filing date
FAQ
What specific listing rule or standard has Rocky Mountain Chocolate Factory failed to satisfy?
The filing does not specify the exact rule or standard that has not been met, only that a notice of delisting or failure to satisfy a continued listing rule or standard has been issued.
What is the earliest event date reported in this 8-K filing?
The earliest event reported is November 14, 2024.
What is the principal executive office address for Rocky Mountain Chocolate Factory, Inc.?
The principal executive offices are located at 265 Turner Drive, Durango, Colorado 81303.
What is the Commission File Number for Rocky Mountain Chocolate Factory, Inc.?
The Commission File Number is 001-36865.
What is the IRS Employer Identification Number for Rocky Mountain Chocolate Factory, Inc.?
The IRS Employer Identification Number is 47-1535633.
Filing Stats: 1,070 words · 4 min read · ~4 pages · Grade level 15.7 · Accepted 2024-11-20 16:06:14
Key Financial Figures
- $0.001 — ge on which registered Common Stock , $0.001 par value per share RMCF Nasdaq Glo
Filing Documents
- rmcfd20241118_8k.htm (8-K) — 28KB
- logo.jpg (GRAPHIC) — 8KB
- 0001437749-24-035862.txt ( ) — 179KB
- rmcf-20241114.xsd (EX-101.SCH) — 3KB
- rmcf-20241114_def.xml (EX-101.DEF) — 11KB
- rmcf-20241114_lab.xml (EX-101.LAB) — 15KB
- rmcf-20241114_pre.xml (EX-101.PRE) — 11KB
- rmcfd20241118_8k_htm.xml (XML) — 3KB
01
Item 3.01. Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. On November 14, 2024, Rocky Mountain Chocolate Factory, Inc. (the "Company") received a deficiency letter (the "Nasdaq Letter") from the Nasdaq Listing Qualifications Department, notifying the Company that the Company is not in compliance with Nasdaq Listing Rule 5605. As a result of the director resignation disclosed in the Current Report on Form 8-K filed by the Company on November 7, 2024 , the Company is no longer in compliance with the following (collectively, the "Corporate Governance Requirements"): Nasdaq Listing Rule 5605(b), which requires, among other things, that a majority of the Company's Board of Directors be comprised of Independent Directors (as defined in Nasdaq Listing Rule 5605(a)(2)); Nasdaq Listing Rule 5605(c), which requires, among other things, that the Company have an Audit Committee that has at least three members, each of whom must (i) be an Independent Director, (ii) meet the criteria for independence set forth in Rule 10A-3(b)(1) under the Securities Exchange Act of 1934, as amended, (iii) not have participated in the preparation of the financial statements of the Company or any current subsidiary of the Company at any time during the past three years, and (iv) be able to read and understand fundamental financial statements; In accordance with Nasdaq Listing Rule 5605(c)(4)(B), the Company is entitled to a cure period to regain compliance, which cure period will expire at the earlier of its 2025 annual meeting of stockholders (which is expected to take place in August 2025) or November 6, 2025. The Company intends to appoint an additional independent director to its Board and the Audit Committee prior to the end of the cure period. Neither the Nasdaq Letter nor the Company's noncompliance with the Corporate Governance Requirements has an immediate effect on the listing or trading of the Company's common stock, which wi